coin-img-ETHETH+0.64%coin-img-BTCBTC+1.17%coin-img-SOLSOL+0.12%coin-img-XRPXRP+0.50%coin-img-USDCUSDC-0.03%coin-img-NEARNEAR-8.36%coin-img-HYPEHYPE-4.50%coin-img-SUISUI+1.97%coin-img-ETHETH+0.64%coin-img-BTCBTC+1.17%coin-img-SOLSOL+0.12%coin-img-XRPXRP+0.50%coin-img-USDCUSDC-0.03%coin-img-NEARNEAR-8.36%coin-img-HYPEHYPE-4.50%coin-img-SUISUI+1.97%coin-img-ETHETH+0.64%coin-img-BTCBTC+1.17%coin-img-SOLSOL+0.12%coin-img-XRPXRP+0.50%coin-img-USDCUSDC-0.03%coin-img-NEARNEAR-8.36%coin-img-HYPEHYPE-4.50%coin-img-SUISUI+1.97%coin-img-ETHETH+0.64%coin-img-BTCBTC+1.17%coin-img-SOLSOL+0.12%coin-img-XRPXRP+0.50%coin-img-USDCUSDC-0.03%coin-img-NEARNEAR-8.36%coin-img-HYPEHYPE-4.50%coin-img-SUISUI+1.97%
user-avatar
MarketScreener

Sanofi and Regeneron expand immunology drug alliance in deal valued at up to $8 billion

AI Market Summary
European equities opened lower as an accelerating sovereign bond selloff pushed yields to multiyear highs, tightening financial conditions and weighing on rate-sensitive sectors. The euro slid to a 16-month low versus the dollar while the dollar index strengthened on renewed expectations for higher U.S. rates, despite softer PCE. Swiss inflation firmed on higher imported energy prices, reinforcing the macro headwinds driving risk-off positioning.
Impact level
● High
Affected assets
NCSIDXY2USD/USDT+0.58%
AI Insight · NCSIDXY2USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Sanofi and Regeneron Pharmaceuticals have agreed to expand their partnership to jointly develop and commercialize new immunology drugs. Under the deal, Regeneron will receive $1 billion upfront from its European partner. It may also be eligible for up to $7 billion tied to development, regulatory and commercial milestones, bringing the agreement’s potential value to as much as $8 billion.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Finance

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.